Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Randall J Roper

Showing results (21-30 of 49) with videos related to

Pageof 5
Sort By:
Genetics|September 21, 2005
Perinatal loss of Ts65Dn Down syndrome miceRandall J Roper, Heidi K St John, Jessica Philip, et al.
Scientific Reports|June 28, 2020
Evaluation of the therapeutic potential of Epigallocatechin-3-gallate (EGCG) via oral gavage in young adult Down syndrome miceCharles R Goodlett, Megan Stringer, Jonathan LaCombe, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 21, 2008
Cutting edge: Autoimmune disease in day 3 thymectomized mice is actively controlled by endogenous disease-specific regulatory T cellsEileen T Samy, Karen M Wheeler, Randall J Roper, et al.
Neurobiology of Disease|November 22, 2023
Sex-specific developmental alterations in DYRK1A expression in the brain of a Down syndrome mouse modelLaura E Hawley, Megan Stringer, Abigail J Deal, et al.
Complementary Therapies in Medicine|July 24, 2019
Usage of and attitudes about green tea extract and Epigallocathechin-3-gallate (EGCG) as a therapy in individuals with Down syndromeRachel Long, Montana L Drawbaugh, Charlene M Davis, et al.
Mechanisms of Development|January 4, 2015
Abnormal mineralization of the Ts65Dn Down syndrome mouse appendicular skeleton begins during embryonic development in a Dyrk1a-independent mannerJoshua D Blazek, Ahmed M Malik, Maeve Tischbein, et al.
JCI Insight|April 19, 2019
Down syndrome mouse models have an abnormal enteric nervous systemEllen M Schill, Christina M Wright, Alisha Jamil, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 25, 2006
Defective cerebellar response to mitogenic Hedgehog signaling in Down [corrected] syndrome miceRandall J Roper, Laura L Baxter, Nidhi G Saran, et al.
Biorxiv : the Preprint Server for Biology|June 3, 2024
Sex specific emergence of trisomic <i>Dyrk1a</i>-related skeletal phenotypes in the development of a Down syndrome mouse modelJonathan M LaCombe, Kourtney Sloan, Jared R Thomas, et al.
Plos One|February 23, 2022
Increased dosage and treatment time of Epigallocatechin-3-gallate (EGCG) negatively affects skeletal parameters in normal mice and Down syndrome mouse modelsRaza Jamal, Jonathan LaCombe, Roshni Patel, et al.
Pageof 5

Showing results (21-30 of 49) with videos related to

Sort By:
Pageof 5
Genetics|September 21, 2005
Perinatal loss of Ts65Dn Down syndrome miceRandall J Roper, Heidi K St John, Jessica Philip, et al.
Scientific Reports|June 28, 2020
Evaluation of the therapeutic potential of Epigallocatechin-3-gallate (EGCG) via oral gavage in young adult Down syndrome miceCharles R Goodlett, Megan Stringer, Jonathan LaCombe, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 21, 2008
Cutting edge: Autoimmune disease in day 3 thymectomized mice is actively controlled by endogenous disease-specific regulatory T cellsEileen T Samy, Karen M Wheeler, Randall J Roper, et al.
Neurobiology of Disease|November 22, 2023
Sex-specific developmental alterations in DYRK1A expression in the brain of a Down syndrome mouse modelLaura E Hawley, Megan Stringer, Abigail J Deal, et al.
Complementary Therapies in Medicine|July 24, 2019
Usage of and attitudes about green tea extract and Epigallocathechin-3-gallate (EGCG) as a therapy in individuals with Down syndromeRachel Long, Montana L Drawbaugh, Charlene M Davis, et al.
Mechanisms of Development|January 4, 2015
Abnormal mineralization of the Ts65Dn Down syndrome mouse appendicular skeleton begins during embryonic development in a Dyrk1a-independent mannerJoshua D Blazek, Ahmed M Malik, Maeve Tischbein, et al.
JCI Insight|April 19, 2019
Down syndrome mouse models have an abnormal enteric nervous systemEllen M Schill, Christina M Wright, Alisha Jamil, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 25, 2006
Defective cerebellar response to mitogenic Hedgehog signaling in Down [corrected] syndrome miceRandall J Roper, Laura L Baxter, Nidhi G Saran, et al.
Biorxiv : the Preprint Server for Biology|June 3, 2024
Sex specific emergence of trisomic <i>Dyrk1a</i>-related skeletal phenotypes in the development of a Down syndrome mouse modelJonathan M LaCombe, Kourtney Sloan, Jared R Thomas, et al.
Plos One|February 23, 2022
Increased dosage and treatment time of Epigallocatechin-3-gallate (EGCG) negatively affects skeletal parameters in normal mice and Down syndrome mouse modelsRaza Jamal, Jonathan LaCombe, Roshni Patel, et al.
Pageof 5